Viewing Study NCT05942768


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2025-12-29 @ 8:53 PM
Study NCT ID: NCT05942768
Status: COMPLETED
Last Update Posted: 2023-07-12
First Post: 2023-07-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
Sponsor: Hunan Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module